The VA is launching a groundbreaking clinical trial to test if GLP-1 drugs—used for diabetes and weight loss—can help veterans cut down on alcohol use, reduce ER visits, and improve quality of life. With 600 vets across 18 medical centers enrolled, this study could reshape treatment options for alcohol use disorder and reflect the VA’s commitment to innovative, veteran-centered care.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
